Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Anti-inflammatory Properties of Cannabidiol, a Nonpsychotropic Cannabinoid, in Experimental Allergic Contact Dermatitis
Stefania Petrosino, Roberta Verde, Massimo Vaia, et al.
Journal of Pharmacology and Experimental Therapeutics (2018) Vol. 365, Iss. 3, pp. 652-663
Open Access | Times Cited: 139

Showing 26-50 of 139 citing articles:

Biological effects of Cannabidiol on normal human healthy cell populations: Systematic review of the literature
Stefano Pagano, Maddalena Coniglio, Chiara Valenti, et al.
Biomedicine & Pharmacotherapy (2020) Vol. 132, pp. 110728-110728
Open Access | Times Cited: 53
Cannabinoids and Inflammations of the Gut-Lung-Skin Barrier
Cristian Scheau, Constantin Căruntu, Ioana Anca Bădărău, et al.
Journal of Personalized Medicine (2021) Vol. 11, Iss. 6, pp. 494-494
Open Access | Times Cited: 49
Opportunities, Challenges and Pitfalls of Using Cannabidiol as an Adjuvant Drug in COVID-19
Barbara Malinowska, Marta Baranowska‐Kuczko, Aleksandra Kicman, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 4, pp. 1986-1986
Open Access | Times Cited: 46
Cannabis sativa and Skin Health: Dissecting the Role of Phytocannabinoids
Giulia Martinelli, Andrea Magnavacca, Marco Fumagalli, et al.
Planta Medica (2021) Vol. 88, Iss. 07, pp. 492-506
Open Access | Times Cited: 43
In Vitro and Clinical Evaluation of Cannabigerol (CBG) Produced via Yeast Biosynthesis: A Cannabinoid with a Broad Range of Anti-Inflammatory and Skin Health-Boosting Properties
E. Pérez, José R. Fernández, Corey Fitzgerald, et al.
Molecules (2022) Vol. 27, Iss. 2, pp. 491-491
Open Access | Times Cited: 37
Anti-inflammation and gingival wound healing activities of Cannabis sativa L. subsp. sativa (hemp) extract and cannabidiol: An in vitro study
Kheskanya Kongkadee, Wudtichai Wisuitiprot, Kornkanok Ingkaninan, et al.
Archives of Oral Biology (2022) Vol. 140, pp. 105464-105464
Closed Access | Times Cited: 28
Phytocannabinoids in the Pharmacotherapy of Psoriasis
Adam Wroński, Iwona Jarocka-Karpowicz, Anna Stasiewicz, et al.
Molecules (2023) Vol. 28, Iss. 3, pp. 1192-1192
Open Access | Times Cited: 19
The Skin and Natural Cannabinoids–Topical and Transdermal Applications
Silviu-Iulian Filipiuc, Anca-Narcisa Neagu, Cristina Mariana Urîtu, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 7, pp. 1049-1049
Open Access | Times Cited: 19
Beyond Pain Relief: A Review on Cannabidiol Potential in Medical Therapies
Mariana Veiga, João Azevedo‐Silva, João Carlos Fernandes
Pharmaceuticals (2023) Vol. 16, Iss. 2, pp. 155-155
Open Access | Times Cited: 17
Cannabinoids and Their Receptors in Skin Diseases
Eun Hee Yoo, Ji Hyun Lee
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 22, pp. 16523-16523
Open Access | Times Cited: 16
MyD88-dependent and -independent signalling via TLR3 and TLR4 are differentially modulated by Δ9-tetrahydrocannabinol and cannabidiol in human macrophages
John-Mark Fitzpatrick, Eleanor Minogue, Lucy Curham, et al.
Journal of Neuroimmunology (2020) Vol. 343, pp. 577217-577217
Closed Access | Times Cited: 46
Cannabis and the skin
Kimberly Shao, Campbell L. Stewart, Jane M. Grant‐Kels
Clinics in Dermatology (2021) Vol. 39, Iss. 5, pp. 784-795
Closed Access | Times Cited: 39
Effects of cannabinoid (CBD) on blood brain barrier permeability after brain injury in rats
Hongyan Jiang, Hengxi Li, Yan Cao, et al.
Brain Research (2021) Vol. 1768, pp. 147586-147586
Closed Access | Times Cited: 35
Optimizing the Process Design of Oil-in-Water Nanoemulsion for Delivering Poorly Soluble Cannabidiol Oil
Agnieszka Lewińska
Processes (2021) Vol. 9, Iss. 7, pp. 1180-1180
Open Access | Times Cited: 34
Cannabidiol Interacts Antagonistically with Cisplatin and Additively with Mitoxantrone in Various Melanoma Cell Lines—An Isobolographic Analysis
Paweł Marzęda, Paula Wróblewska-Łuczka, Małgorzata Drozd, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 12, pp. 6752-6752
Open Access | Times Cited: 25
Neuroinflammation and neuroprogression in depression: Effects of alternative drug treatments
Brandon Richardson, Andrew J. Macpherson, Francis Rodriguez Bambico
Brain Behavior & Immunity - Health (2022) Vol. 26, pp. 100554-100554
Open Access | Times Cited: 25
Biological effects of cannabidiol on human cancer cells: Systematic review of the literature
Chiara Valenti, Monia Billi, Gian Luca Pancrazi, et al.
Pharmacological Research (2022) Vol. 181, pp. 106267-106267
Closed Access | Times Cited: 24
Pharmacokinetics, efficacy, and safety of cannabidiol in dogs: an update of current knowledge
Alessandra Di Salvo, Maria Beatrice Conti, Giorgia Della Rocca
Frontiers in Veterinary Science (2023) Vol. 10
Open Access | Times Cited: 15
Cutaneous Delivery and Biodistribution of Cannabidiol in Human Skin after Topical Application of Colloidal Formulations
Maria Lapteva, Jonathan Faro Barros, Yogeshvar N. Kalia
Pharmaceutics (2024) Vol. 16, Iss. 2, pp. 202-202
Open Access | Times Cited: 5
Antioxidant and membrane-protective effects of the 3-O-ethyl ascorbic acid-cannabigerol system on UVB-irradiated human keratinocytes
Iwona Jarocka-Karpowicz, Anna Stasiewicz, Ewa Olchowik‐Grabarek, et al.
Free Radical Biology and Medicine (2025) Vol. 228, pp. 251-266
Closed Access
Cannabinoids: Potential Role in Inflammatory and Neoplastic Skin Diseases
Rose Milando, Adam Friedman
American Journal of Clinical Dermatology (2018) Vol. 20, Iss. 2, pp. 167-180
Closed Access | Times Cited: 43
The Current and Potential Application of Medicinal Cannabis Products in Dentistry
Henry Lowe, Ngeh J. Toyang, Blair Steele, et al.
Dentistry Journal (2021) Vol. 9, Iss. 9, pp. 106-106
Open Access | Times Cited: 32
Virtual screening using docking and molecular dynamics of cannabinoid analogs against CB1 and CB2 receptors
Antistio Aviz-Amador, Neyder Contreras‐Puentes, Jairo Mercado‐Camargo
Computational Biology and Chemistry (2021) Vol. 95, pp. 107590-107590
Closed Access | Times Cited: 29
Cancer Initiation, Progression and Resistance: Are Phytocannabinoids from Cannabis sativa L. Promising Compounds?
Ersilia Nigro, Marialuisa Formato, Giuseppina Crescente, et al.
Molecules (2021) Vol. 26, Iss. 9, pp. 2668-2668
Open Access | Times Cited: 27
The current understanding of the benefits, safety, and regulation of cannabidiol in consumer products
Jinpeng Li, Ricardo Carvajal, Leon H. Bruner, et al.
Food and Chemical Toxicology (2021) Vol. 157, pp. 112600-112600
Open Access | Times Cited: 27

Scroll to top